Weiss Multi Strategy Advisers LLC Akebia Therapeutics, Inc. Transaction History

Weiss Multi Strategy Advisers LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$7.44 - $10.65 $105,900 - $151,592	-14,234 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$9.15 - $11.34 $11,291 - $13,993	1,234 Added 9.49%	14,234 $142,000
Q1 2018 May 15, 2018	BUY	$9.53 - $15.68 $123,889 - $203,840	13,000 New	13,000 $124,000

120

54.8M

291K

179K

Ticker AKBA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 183,848,992
Market Cap $324M
Description
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.